P

Inventor

GOSSELIN FRANCIS

US41 patents
⚠️ This page may combine multiple inventors who share the name “GOSSELIN FRANCIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENENTECH INC

25 patents
US10954234B2Mar 23, 2021

Solid forms of 3-((1R,3R)-1-(2,6-difluoro-4-((1-(3- fluoropropyl)azetidin-3-yl)amino)phenyl)-3-methyl-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)-2,2-difluoropropan-1-ol and processes for preparing fused tricyclic compounds comprising a substituted phenyl or pyridinyl moiety, including methods of their use

GENENTECH INC6 citations80
US9315471B2Apr 19, 2016

Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof

GENENTECH INC12 citations80
US10435378B2Oct 8, 2019

Processes for the preparation of pyrimidinylcyclopentane compounds

GENENTECH INC2 citations72
US9862689B2Jan 9, 2018

Processes for the preparation of pyrimidinylcyclopentane compounds

GENENTECH INC4 citations72
US10781219B2Sep 22, 2020

Process for the preparation of (S)-2-((2-((S)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[F]imidazo[1,2-D][1,4]oxazepin-9-yl)amino) propanamide

GENENTECH INC5 citations71
US11661424B2May 30, 2023

Process for preparing BTK inhibitors

GENENTECH INC1 citations70
US10882864B2Jan 5, 2021

Process for preparing BTK inhibitors

GENENTECH INC3 citations70
US10385058B2Aug 20, 2019

Process for preparing BTK inhibitors

GENENTECH INC3 citations70
US9290458B2Mar 22, 2016

Amorphous form of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof

GENENTECH INC4 citations70
US11969426B2Apr 30, 2024

Pharmaceutical compositions comprising Akt protein kinase inhibitors

GENENTECH INC1 citations68
US11337977B2May 24, 2022

Pharmaceutical compositions comprising Akt protein kinase inhibitors

GENENTECH INC3 citations68
US8895729B2Nov 25, 2014

Process for making thienopyrimidine compounds

GENENTECH INC3 citations60
US9505725B2Nov 29, 2016

Crystalline and mesomorphous forms of an AKT inhibiting pyrimidinyl-cyclopentane compound, compositions and methods thereof

GENENTECH INC2 citations59
US12440492B2Oct 14, 2025

Pharmaceutical compositions comprising AKT protein kinase inhibitors

GENENTECH INC0 citations58
US11702452B2Jul 18, 2023

Process for making arylomycin ring analogs

GENENTECH INC0 citations55
US11192924B2Dec 7, 2021

Process for making arylomycin ring analogs

GENENTECH INC0 citations55
US11325912B2May 10, 2022

Regio-selective synthesis of imidazo[1,2-a]pyrimidines

GENENTECH INC0 citations54
US11136330B2Oct 5, 2021

Synthesis of labeled imidazo[1,2-A]pyrimidines

GENENTECH INC0 citations54
US10858324B2Dec 8, 2020

Processes for the preparation of pyrimidinylcyclopentane compounds

GENENTECH INC0 citations51
US11414412B2Aug 16, 2022

Process for the preparation of a medicament

GENENTECH INC0 citations49
US9975856B2May 22, 2018

Process for the preparation of (E)-3-(4-((E)-2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid

GENENTECH INC0 citations47
US11999749B2Jun 4, 2024

Synthesis of a bis-mesylate salt of 4-amino-N-(1-((3-chloro-2-fluorophenyl)amino)-6-methylisoquinolin-5-yl)thieno[3,2-d]pyrimidine-7-carboxamide and intermediates thereto

GENENTECH INC0 citations43
US12172982B2Dec 24, 2024

Synthesis of quinazoline compounds

GENENTECH INC0 citations41
US12071422B2Aug 27, 2024

Process for synthesis of quinazoline compounds

GENENTECH INC0 citations41
US10329288B2Jun 25, 2019

Process for preparing a compound

GENENTECH INC0 citations36

FORMA TM LLC

4 patents

HOFFMANN LA ROCHE

3 patents

VALO HEALTH INC

2 patents

QUEBEC METAL POWDERS LTD

1 patent

BAIR KENNETH W

1 patent

MERCK SHARP & DOHME

1 patent

(unassigned)

1 patent

SIRNA THERAPEUTICS INC

1 patent

MERCK FROSST CANADA LTD

1 patent

O'SHEA PAUL

1 patent